NurExone Biologic Inc. Stock Deutsche Boerse AG
Equities
J90
CA67059R1091
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 EUR | -0.83% | +5.22% | +183.04% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 33.86M 30.96M |
---|---|---|---|---|---|
Net income 2024 * | -4M -3.66M | Net income 2025 * | -4M -3.66M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.3
x | P/E ratio 2025 * |
-6.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.76% |
1 day | -0.83% | ||
1 week | +5.22% | ||
Current month | +10.00% | ||
1 month | +22.84% | ||
3 months | +16.91% | ||
6 months | +189.82% | ||
Current year | +183.04% |
Managers | Title | Age | Since |
---|---|---|---|
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Eran Ovadya
DFI | Director of Finance/CFO | - | 22-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Richardson
BRD | Director/Board Member | 78 | 22-01-02 |
Gadi Riesenfeld
BRD | Director/Board Member | 79 | 23-07-05 |
Yoram Drucker
CHM | Chairman | 59 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-17 | 0.484 | +7.56% | 8 300 |
24-07-16 | 0.45 | -3.85% | 12,000 |
24-07-15 | 0.468 | +5.41% | 8,100 |
24-07-12 | 0.444 | +6.73% | 7,500 |
24-07-11 | 0.416 | -9.57% | 1,000 |
Delayed Quote Deutsche Boerse AG, July 17, 2024 at 05:46 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+43.96% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- NRX Stock
- J90 Stock